Rankings
▼
Calendar
AMRX Q2 2017 Earnings — Amneal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
AMRX
Amneal Pharmaceuticals, Inc.
$4B
Q2 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$260M
Gross Profit
$124M
47.6% margin
Operating Income
$45M
17.2% margin
Net Income
$37M
14.4% margin
EPS (Diluted)
$0.33
QoQ Revenue Growth
+15.1%
Cash Flow
Operating Cash Flow
$26M
Free Cash Flow
-$4M
Stock-Based Comp.
$0
← FY 2017
All Quarters
Q3 2017 →
